President Bush's family has made a lot of money from drug companies and still has very close ties to the pharmaceutical industry. (Bush Sr was on Eli Lilly's board of directors and Bush Jr appointed Lilly's CEO to a senior position on the Homeland Security Council.)
According to this British Medical Journal article, "Lilly made $1.6m in political contributions in 2000—82% of which went to Bush and the Republican Party. "
So it's not surprising that the President announced a plan to screen the entire US population for mental illness and pump lots and lots of people full of expensive Eli Lilly drugs. Bush's commission has recommended that the federal government adopt a model based on the Texas Medication Algorithm Project (TMAP) a medication treatment plan that recommends Zyprexa as a first line antipsychotic drug for patients. Bush was governor of Texas when the plan was adopted, and Zyprexa coincidentally happens to be made Eli Lilly. It's the drug company's top seller, grossing $4.28 billion dollars last year. According to the article, "A 2003 New York Times article by Gardiner Harris reported that 70% of olanzapine sales are paid for by government agencies, such as Medicare and Medicaid."
But the Texas project, which promotes the use of newer, more expensive antidepressants and antipsychotic drugs, sparked off controversy when Allen Jones, an employee of the Pennsylvania Office of the Inspector General, revealed that key officials with influence over the medication plan in his state received money and perks from drug companies with a stake in the medication algorithm (15 May, p1153). He was sacked this week for speaking to the BMJ and the New York Times.
Mr Jones told the BMJ that the same "political/pharmaceutical alliance" that generated the Texas project was behind the recommendations of the New Freedom Commission, which, according to his whistleblower report, were "poised to consolidate the TMAP effort into a comprehensive national policy to treat mental illness with expensive, patented medications of questionable benefit and deadly side effects, and to force private insurers to pick up more of the tab."
